- Am J Epidemiol. 2022 Oct 13:kwac181. doi: 10.1093/aje/kwac181. Epub ahead of print.
- Smith J, Cohen T, Dowdy D, Shrestha S, Gandhi NR, Hill AN.
Archives: Publications
Publications
Analyzing Pragmatic Trials to Inform Cost-Effectiveness Analyses
- Value Health. 2022 Oct 29:S1098-3015(22)04688-5.
- Dowdy DW, Thompson RR, Kityamuwesi A, Crowder R, Cattamanchi A, Katamba A, Sohn H.
Tuberculosis treatment adherence in the era of COVID-19.”
- BMC Infect Dis. 2022 Oct 26;22(1):800. doi: 10.1186/s12879-022-07787-4. PMID: 36289485; PMCID: PMC9607764.
- Lippincott CK, Perry A, Munk E, Maltas G, Shah M.
Tuberculosis Epidemiologic Studies Consortium. Evaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States
- Clin Infect Dis. 2022 Nov 14;75(10):1792-1799. doi: 10.1093/cid/ciac248. PMID: 35363249.
- Holzman SB, Perry A, Saleeb P, Pyan A, Keh C, Salcedo K, Narita M, Ahmed A, Miller TL, Pettit AC, Khurana R, Whipple M, Katz D, Largen A, Krueger A, Shah M.
Diagnostic biomarkers for active tuberculosis: progress and challenges
- EMBO Mol Med. 2022 Oct 31;e14088. doi: 10.15252/emmm.202114088
- Betânia M F Nogueira # 1 2 3, Sonya Krishnan # 4, Beatriz Barreto-Duarte 3 5 6 7, Mariana Araújo-Pereira 3 7 8, Artur T L Queiroz 2 9, Jerrold J Ellner 10, Padmini Salgame 10, Thomas J Scriba 11, Timothy R Sterling 12, Amita Gupta 4, Bruno B Andrade 3 5 7 8 13 14
An intranasal stringent response vaccine targeting dendritic cells as a novel adjunctive therapy against tuberculosis
Front Immunol. 2022 Sep 16;13:972266. doi: 10.3389/fimmu.2022.972266. eCollection 2022.
Styliani Karanika 1 2, James T Gordy 3, Pranita Neupane 1 2, Theodoros Karantanos 4, Jennie Ruelas Castillo 1 2, Darla Quijada 1 2, Kaitlyn Comstock 3, Avinaash K Sandhu 3, Aakanksha R Kapoor 1 3, Yinan Hui 3, Samuel K Ayeh 1 2, Rokeya Tasneen 1 2, Stefanie Krug 1 2, Carina Danchik 1 2, Tianyin Wang 3, Courtney Schill 3, Richard B Markham 3, Petros C Karakousis 1 2